| 
			
			 The procedure can yield "excellent short- and mid-term outcomes in a 
			patient population with a lethal disease that without this 
			technology would undoubtedly die,” Dr. Vinod H. Thourani from Emory 
			University, Atlanta, Georgia told Reuters Health by email. 
 The results of the study, involving patients in their nineties, were 
			"surprising and quite honestly rewarding," Thourani added.
 
 Known as transcatheter aortic valve replacement (TAVR), the new 
			technique has been revolutionizing the care of patients with a 
			narrowed aortic valve (so-called aortic stenosis) who are too frail 
			to undergo the traditional "open" surgery.
 
 Instead of cutting through the chest to reach the heart, doctors 
			insert the new valve through a catheter that's been threaded into 
			the heart through a small incision in the arm or the groin.
 
			
			 
			  
			For the current study, Thourani and colleagues looked specifically 
			at outcomes in some of the oldest patients to participate in a large 
			randomized trial called PARTNER-I, which was the first multicenter 
			randomized trial to show the superiority of TAVR over medical 
			therapy.
 In the 531 nonagenarians who underwent TAVR, procedural success 
			rates were 74 to 78 percent, the researchers reported in Annals of 
			Thoracic Surgery.
 
 Within the first 30 days after TAVR, roughly a third of the patients 
			had some kind of major complication - such as a stroke, renal 
			failure, or need for a pacemaker - and 38 patients (7 percent) died.
 
			
            [to top of second column] | 
 
			But once patients recovered from the surgery, their risk of death 
			was equivalent to that of the general population, according to the 
			researchers. 
			By six months after TAVR, patients were reporting significantly 
			better quality of life than they had at baseline, the researchers 
			found.
 These extremely elderly patients would face very high risks from 
			open surgical valve replacement, but "with the advent of this TAVR 
			procedure, cardiac surgeons and cardiologists are able to offer 
			these well-deserving patients a treatment option that otherwise 
			would have been prohibitive,” Thourani said.
 
 SOURCE: http://bit.ly/1Fg5mtg Annals of Thoracic Surgery, online 
			August 1, 2015.
 
			[© 2015 Thomson Reuters. All rights 
				reserved.] Copyright 2015 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed. 
			
			
			 |